Evidence map›Paper›PMID 35217454›Full record

ArticleMedical image analysis2022

NaroNet: Discovery of tumor microenvironment elements from highly multiplexed images.

Daniel Jiménez-Sánchez, Mikel Ariz, Hang Chang, Xavier Matias-Guiu, Carlos E de Andrea, Carlos Ortiz-de-Solórzano

Abstract read
In one paragraph

Article in Medical image analysis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Guideline
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Data-Rich Spatial Profiling of Cancer Tissue: Astronomy Informs Pathology.Clinical cancer research : an official journal of the American Association for Cancer Research · 2022
    Article
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Daniel Jiménez-SánchezSolid Tumors and Biomarkers Program, IDISNA, and Ciberonc, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain; Biological Systems and Engineering Division, Lawrence Berkeley National Laboratory, CA, 94720, Berkeley, USA.
Mikel ArizSolid Tumors and Biomarkers Program, IDISNA, and Ciberonc, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain.
Hang ChangBiological Systems and Engineering Division, Lawrence Berkeley National Laboratory, CA, 94720, Berkeley, USA.
Xavier Matias-GuiuDepartment of Pathology, Hospital U Arnau de Vilanova and Hospital U de Bellvitge, Universities of Lleida and Barcelona, IDIBELL, IRBLLEIDA, CIBERONC, Lleida, 25198, Spain.
Carlos E de AndreaDepartment of Pathology, IDISNA, Ciberonc, Clínica Universidad de Navarra, University of Navarra, Pamplona, 31008, Spain.
Carlos Ortiz-de-SolórzanoSolid Tumors and Biomarkers Program, IDISNA, and Ciberonc, Center for Applied Medical Research, University of Navarra, Pamplona, 31008, Spain. Electronic address: codesolorzano@unav.es.

Funding

Molecular and Therapeutic Basis of Morphometric Aberrations in Brain TumorsR01CA184476 · NCI · UNIVERSITY OF CALIF-LAWRENC BERKELEY LAB · PI CHANG, HANG · 2015 to 2019
$2.0M
NCI NIH HHS R01 CA184476
6 · The paper itself

Abstract

Understanding the spatial interactions between the elements of the tumor microenvironment -i.e. tumor cells. fibroblasts, immune cells- and how these interactions relate to the diagnosis or prognosis of a tumor is one of the goals of computational pathology. We present NaroNet, a deep learning framework that models the multi-scale tumor microenvironment from multiplex-stained cancer tissue images and provides patient-level interpretable predictions using a seamless end-to-end learning pipeline. Trained only with multiplex-stained tissue images and their corresponding patient-level clinical labels, NaroNet unsupervisedly learns which cell phenotypes, cell neighborhoods, and neighborhood interactions have the highest influence to predict the correct label. To this end, NaroNet incorporates several novel and state-of-the-art deep learning techniques, such as patch-level contrastive learning, multi-level graph embeddings, a novel max-sum pooling operation, or a metric that quantifies the relevance that each microenvironment element has in the individual predictions. We validate NaroNet using synthetic data simulating multiplex-immunostained images where a patient label is artificially associated to the -adjustable- probabilistic incidence of different microenvironment elements. We then apply our model to two sets of images of human cancer tissues: 336 seven-color multiplex-immunostained images from 12 high-grade endometrial cancer patients; and 382 35-plex mass cytometry images from 215 breast cancer patients. In both synthetic and real datasets, NaroNet provides outstanding predictions of relevant clinical information while associating those predictions to the presence of specific microenvironment elements.

Indexed as

Breast NeoplasmsTumor MicroenvironmentFemaleHumansPrognosisCellular neighborhoodsDeep learningImaging mass cytometryInterpretable machine learningMultiplex imagingSelf supervised learningSpatial biologyTumor microenvironmentWeakly supervised learning

Identifiers

PMID35217454
PMCPMC9972483

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.